Added to YB: 2025-02-04
Pitch date: 2025-02-03
ALCAR.PA [neutral]
Carmat SA
-87.7%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Carmat SA designs and develops total artificial heart for patients with advanced heart failure in France and internationally.
Market Cap
EUR 6.1M
Pitch Price
EUR 0.81
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.25
P/E
-0.09
EV/Sales
8.07
Sector
Professional Services
Category
N/A
Show full summary:
Creams, Semis and Oil - Carmat
ALCAR.PA (overview): €9.7M raised at 29% discount, sustains ops till May 2025. Need €35M more for next year. 2024 sales €7M, aim to double in 2025. Medtech capital-intensive. Key: secure funding for growth vs dilution risk. Can they meet ambitious sales targets?
Read full article (1 min)